TSX News -
Euro Sun Appoints Peter Vukanovich and Paul Perrow to Board of Directors
TORONTO, June 30, 2020 (GLOBE NEWSWIRE) — Euro Sun Mining Inc. (TSX: ESM) (“Euro Sun” or the “Company”) is pleased […]
Nouveau Monde receives $1.5M in funding to develop spherical graphite
SAINT-MICHEL-DES-SAINTS, Quebec, June 30, 2020 (GLOBE NEWSWIRE) — Committed to developing a low-carbon option for the spherical graphite market currently […]
SmartGATE™ Installation Completed in New York at a Major Multi-Family Site in Manhattan
VANCOUVER, British Columbia, June 30, 2020 (GLOBE NEWSWIRE) — Legend Power® Systems (TSX-V: LPS), a global leader in onsite energy […]
POET and Sanan IC Sign LOI to Form $50 Million Joint Venture
TORONTO, June 30, 2020 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK; OTCQX: POETF), the […]
Intrepid Sets Date for Shareholder Vote on Reverse Stock Split
DENVER, CO, June 30, 2020 (GLOBE NEWSWIRE) — Intrepid Potash Inc. (NYSE:IPI) (“Intrepid”) has scheduled a special meeting of stockholders […]
Methode Electronics, Inc. Reports Fiscal 2020 Fourth Quarter and Record Full Year Financial Results
Record Fiscal 2020 Net Sales of $1,023.9 MillionRecord Fiscal 2020 Diluted Income per Share of $3.26Record Fiscal 2020 Free Cash […]
XPO Logistics Recognized by General Motors as Supplier of the Year for Managed Transportation
GREENWICH, Conn., June 30, 2020 (GLOBE NEWSWIRE) — XPO Logistics, Inc. (NYSE: XPO), a leading global provider of transportation and logistics […]
Trillion Energy Engaged in Development Planning for SASB Redevelopment
VANCOUVER, British Columbia and ANKARA, Turkey, June 30, 2020 (GLOBE NEWSWIRE) — Trillion Energy International Inc. (“Trillion” or the “Company”) […]
Cara Therapeutics Expands Board of Directors with Appointment of Susan Shiff, Ph.D., M.B.A.
STAMFORD, Conn., June 30, 2020 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and […]
GW Pharmaceuticals Presents Nabiximols U.S. Development and Commercial Strategy
– Potential accelerated pathway to NDA submission – – Clinical program of five Phase 3 trials provides multiple options for NDA […]
